Hepatitis Clinical Trials in Chicago

Showing 241-242 of 242 trials

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

NCT00044135

The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.

Hepatitis B

Triangle Pharmaceuticals30 participantsStarted Aug 2002

Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States • Vancouver, Canada +8 more locations

UNKNOWNPhase 2483 miles

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

NCT00069511

This is a multi-center study. Neither the study subjects nor the physicians will know what treatment an individual subject is receiving. Subjects will be randomly assigned (like flipping a coin) to one of five treatment groups. The treatment groups include four different dosing groups of active study drug and one group of subjects who will receive placebo. A 12 week follow up period occurs after the 12 weeks of dosing. The study endpoint is a reduction in Hepatitis C viral load.

Hepatitis C

United Therapeutics72 participantsStarted Jul 2003

Gainesville, Florida, United States • New Orleans, Louisiana, United States • Boston, Massachusetts, United States +3 more locations

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

Hepatitis Trials in Other Cities

Other Conditions in Chicago